期刊文献+

基质金属蛋白酶-9对骨肉瘤细胞可溶性MICA蛋白形成的影响 被引量:2

Effect of matrix metalloproteinase-9 on the formation of soluble MICA protein in osteosarcoma cells
下载PDF
导出
摘要 目的:探讨基质金属蛋白酶-9(MMP-9)对骨肉瘤细胞可溶性MICA(s MICA)蛋白形成的影响,为骨肉瘤免疫治疗提供新靶点。方法:脂质体法转染MMP-9反义寡核苷酸到骨肉瘤细胞U2OS,应用RT-PCR、明胶酶谱法和ELISA检测转染寡核苷酸后U2OS细胞MMP-9 m RNA表达,以及培养上清液中MMP-9的酶活性和s MICA蛋白浓度变化。结果:U2OS细胞转染MMP-9反义寡核苷酸后,MMP-9 m RNA表达及酶活性受到抑制;培养上清液中s MICA蛋白浓度下降(P=0.011)。结论:MMP-9可能参与骨肉瘤细胞s MICA蛋白形成,MMP-9可作为骨肉瘤免疫治疗的侯选靶点。 Objective To provide a new putative target for immunotherapy on osteosarcoma and explore the effect of matrix metalloproteinase-9 (MMP-9) on the formation of soluble MICA protein in osteosarcoma cells. Methods MMP-9 antisense oligonucleotide was transfected to osteosarcoma cells with lipofeetamine 2000. MMP-9 mRNA was assessed by RT-PCR. MMP-9 activity and soluble MICA (sMICA) in the culture supernatant was examined by zymography and quantified by ELISA, respectively. Results MMP-9 mRNA expression and gelatin enzymatic activity were inhibited in MMP-9 antisense oligonucleotide group. Comparing with the control group, lower concentration of sMICA was found in MMP-9 antisense oligonueleotide group (P = 0.011). Conclusion MMP-9 may have an effect on the formation of sMICA protein in osteosarcoma. MMP-9 could be regarded as a putative target for immunotherapy in osteosarcoma.
出处 《实用医学杂志》 CAS 北大核心 2015年第11期1741-1744,共4页 The Journal of Practical Medicine
基金 广东省医学科研基金立项课题(编号:B2009268)
关键词 骨肉瘤 MHC I类链相关蛋白A 基质金属蛋白酶-9 可溶性MICA Osteosarcoma MHC class I chain-related A Matrix metalloproteinase-9 Soluble MICA
  • 相关文献

参考文献4

二级参考文献58

  • 1Raulet DH.Roles of the NKG2D immunoreceptor and its ligands[J].Nat Rev Immunol,2003,3(10):781-790.
  • 2Watson NF,Spendlove I,Madjd Z,et al.Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients[J].Int J Cancer,2006,118(6):1445-1452.
  • 3Madjd Z,Spendlove I,Moss R,et al.Upregulation of MICA on high-grade invasive operable breast carcinoma[J].Cancer Immun,2007,7(6):17-19.
  • 4Wu JD,Higgins LM,Steinle A,et al.Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer[J].J Clin Invest,2004,114(4):560-568.
  • 5Busche A,Goldmann T,Naumann U,et al.Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A[J].Hum Gene Ther,2006,17(2):135-146.
  • 6Groh V,Bahram S,Bauer S,et al.Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium[J].Proc Natl Acad Sci USA,1996,93(22):12445-12450.
  • 7Friese MA,Platten M,Lutz SZ,et al.MICA/NKG2D-mediated immunogene therapy of experimental gliomas[J].Cancer Res,2003,63(24):8996-9006.
  • 8Oppenheim DE,Roberts SJ,Clarke SL,et al.Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance[J].Nat Immunol,2005,6(9):928-937.
  • 9Kriegeskorte AK,Gebhardt FE,Porcellini S,et al.NKG2D-independent suppression of T cell proliferation by H60 and MICA[J].Proc Natl Acad Sci U S A,2005,102(33):11805-11810.
  • 10Strid J,Roberts SF,Filler RB,et al.Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis[J].Nat Immunol,2008,9(2):146-154.

共引文献4

同被引文献15

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部